Outset Medical, Inc. reaffirmed its previously provided guidance for 2024, including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.905 USD | +6.11% | +9.69% | -27.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.82% | 202M | |
+11.31% | 226B | |
+15.50% | 198B | |
+18.83% | 142B | |
+30.38% | 111B | |
+3.00% | 65.26B | |
+18.31% | 54.36B | |
+4.96% | 50.94B | |
+9.95% | 44.8B | |
+4.27% | 36.8B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for 2024